{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:14:55Z","timestamp":1778634895012,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T00:00:00Z","timestamp":1703203200000},"content-version":"am","delay-in-days":355,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2021R1A4A1031220"],"award-info":[{"award-number":["2021R1A4A1031220"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019803","name":"Oklahoma State University Center for Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001821","name":"Vienna Science and Technology Fund","doi-asserted-by":"publisher","award":["LSC17-026"],"award-info":[{"award-number":["LSC17-026"]}],"id":[{"id":"10.13039\/501100001821","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ejphar.2022.175454","type":"journal-article","created":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T02:09:10Z","timestamp":1671415750000},"page":"175454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["(+)-Catharanthine and (-)-18-methoxycoronaridine induce antidepressant-like activity in mice by differently recruiting serotonergic and norepinephrinergic neurotransmission"],"prefix":"10.1016","volume":"939","author":[{"given":"Hugo R.","family":"Arias","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"De Deurwaerd\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"El-Kasaby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Di Giovanni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanung","family":"Eom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junho H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Freissmuth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2875-2453","authenticated-orcid":false,"given":"Abdeslam","family":"Chagraoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.ejphar.2022.175454_bib1","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.2174\/1381612824666180803111240","article-title":"Recent developments on future antidepressant-related serotonin receptors","volume":"24","author":"Amidfar","year":"2018","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejphar.2022.175454_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.109930","article-title":"Coronaridine congeners potentiate GABA(A) receptors and induce sedative activity in mice in a benzodiazepine-insensitive manner","volume":"101","author":"Arias","year":"2020","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2022.175454_bib3","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.biocel.2017.10.006","article-title":"Selectivity of coronaridine congeners at nicotinic acetylcholine receptors and inhibitory activity on mouse medial habenula","volume":"92","author":"Arias","year":"2017","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejphar.2022.175454_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108194","article-title":"Coronaridine congeners decrease neuropathic pain in mice and inhibit \u03b19\u03b110 nicotinic acetylcholine receptors and CaV2.2 channels","volume":"175","author":"Arias","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2022.175454_bib5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.biocel.2015.05.015","article-title":"Coronaridine congeners inhibit human alpha3beta4 nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites","volume":"65","author":"Arias","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175454_bib6","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1021\/acsptsci.0c00102","article-title":"Tropane-based ibogaine analog rescues folding-deficient serotonin and dopamine transporters","volume":"4","author":"Bhat","year":"2021","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"40","key":"10.1016\/j.ejphar.2022.175454_bib7","doi-asserted-by":"crossref","first-page":"16773","DOI":"10.1074\/jbc.M117.794081","article-title":"Conformational state interactions provide clues to the pharmacochaperone potential of serotonin transporter partial substrates","volume":"292","author":"Bhat","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ejphar.2022.175454_bib8","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1042\/BST20180512","article-title":"How to rescue misfolded SERT, DAT and NET: targeting conformational intermediates with atypical inhibitors and partial releasers","volume":"47","author":"Bhat","year":"2019","journal-title":"Biochem. Soc. Trans."},{"issue":"22","key":"10.1016\/j.ejphar.2022.175454_bib9","doi-asserted-by":"crossref","first-page":"18524","DOI":"10.1074\/jbc.M112.343681","article-title":"The mechanistic basis for noncompetitive ibogaine inhibition of serotonin and dopamine transporters","volume":"287","author":"Bulling","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.ejphar.2022.175454_bib10","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1369-1600.2010.00251.x","article-title":"Noribogaine, but not 18-MC, exhibits similar actions as ibogaine on GDNF expression and ethanol self-administration","volume":"15","author":"Carnicella","year":"2010","journal-title":"Addiction Biol."},{"issue":"11","key":"10.1016\/j.ejphar.2022.175454_bib11","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1046\/j.1460-9568.2003.02667.x","article-title":"Antidepressant and anxiolytic-like effects in mice lacking the group III metabotropic glutamate receptor mGluR7","volume":"17","author":"Cryan","year":"2003","journal-title":"Eur. J. Neurosci."},{"issue":"5","key":"10.1016\/j.ejphar.2022.175454_bib12","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"Cryan","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"issue":"4-5","key":"10.1016\/j.ejphar.2022.175454_bib13","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","article-title":"The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175454_bib14","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.nbd.2011.10.023","article-title":"Emerging dysfunctions consequent to combined monoaminergic depletions in Parkinsonism","volume":"45","author":"Delaville","year":"2012","journal-title":"Neurobiol. Dis."},{"issue":"43","key":"10.1016\/j.ejphar.2022.175454_bib15","doi-asserted-by":"crossref","first-page":"30799","DOI":"10.1074\/jbc.274.43.30799","article-title":"The pharmacological and functional characteristics of the serotonin 5-HT(3A) receptor are specifically modified by a 5-HT(3B) receptor subunit","volume":"274","author":"Dubin","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.ejphar.2022.175454_bib16","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1097\/00001756-200006260-00008","article-title":"Acute treatments with GMP produce antidepressant-like effects in mice","volume":"11","author":"Eckeli","year":"2000","journal-title":"Neuroreport"},{"issue":"1","key":"10.1016\/j.ejphar.2022.175454_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1527-3458.1999.tb00084.x","article-title":"(\u00b1)\u201018\u2010Methoxycoronaridine: a novel iboga alkaloid congener having potential anti\u2010addictive efficacy","volume":"5","author":"Glick","year":"1999","journal-title":"CNS Drug Rev."},{"issue":"3","key":"10.1016\/j.ejphar.2022.175454_bib18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0014-2999(91)90474-5","article-title":"Effects and aftereffects of ibogaine on morphine self-administration in rats","volume":"195","author":"Glick","year":"1991","journal-title":"Eur. J. Pharmacol."},{"issue":"1-3","key":"10.1016\/j.ejphar.2022.175454_bib19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2011.08.001","article-title":"Brain regions mediating alpha3beta4 nicotinic antagonist effects of 18-MC on nicotine self-administration","volume":"669","author":"Glick","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.ejphar.2022.175454_bib20","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.lfs.2010.12.016","article-title":"Automated experimental system capturing three behavioral components during murine forced swim test","volume":"88","author":"Hayashi","year":"2011","journal-title":"Life Sci."},{"issue":"40","key":"10.1016\/j.ejphar.2022.175454_bib21","doi-asserted-by":"crossref","first-page":"29441","DOI":"10.1074\/jbc.M704456200","article-title":"Ibogaine, a noncompetitive inhibitor of serotonin transport, acts by stabilizing the cytoplasm-facing state of the transporter","volume":"282","author":"Jacobs","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175454_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010544","article-title":"Hydroxy pentacyclic triterpene acid, kaempferol, inhibits the human 5-hydroxytryptamine type 3A receptor activity","volume":"23","author":"Lee","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175454_bib23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/bmc.3244","article-title":"Liquid chromatography mass spectrometry simultaneous determination of vindoline and catharanthine in rat plasma and its application to a pharmacokinetic study","volume":"29","author":"Lin","year":"2015","journal-title":"Biomed. Chromatogr."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175454_bib24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.bbr.2004.09.004","article-title":"Structure of the rat behaviour in the forced swimming test","volume":"158","author":"Lino-de-Oliveira","year":"2005","journal-title":"Behav. Brain Res."},{"issue":"9","key":"10.1016\/j.ejphar.2022.175454_bib25","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1080\/17425255.2021.1944099","article-title":"Evaluating the toxicity and therapeutic potential of ibogaine in the treatment of chronic opioid abuse","volume":"17","author":"Luz","year":"2021","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"issue":"3","key":"10.1016\/j.ejphar.2022.175454_bib26","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0091-3057(03)00119-9","article-title":"Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment","volume":"75","author":"Maisonneuve","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175454_bib27","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s002130100687","article-title":"Limitations on the use of the C57BL\/6 mouse in the tail suspension test","volume":"155","author":"Mayorga","year":"2001","journal-title":"Psychopharmacology"},{"issue":"10","key":"10.1016\/j.ejphar.2022.175454_bib28","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1038\/s41386-018-0024-x","article-title":"Interaction between noradrenergic and cholinergic signaling in amygdala regulates anxiety- and depression-related behaviors in mice","volume":"43","author":"Mineur","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"24","key":"10.1016\/j.ejphar.2022.175454_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20246235","article-title":"Vortioxetine subchronically activates serotonergic transmission via desensitization of serotonin 5-HT(1A) receptor with 5-HT(3) receptor inhibition in rats","volume":"20","author":"Okada","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175454_bib30","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s002130051156","article-title":"Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test","volume":"147","author":"Page","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.ejphar.2022.175454_bib31","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/sj.bjp.0704833","article-title":"Comparative pharmacology of rat and human alpha7 nAChR conducted with net charge analysis","volume":"137","author":"Papke","year":"2002","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejphar.2022.175454_bib32","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0091-3057(96)00383-8","article-title":"Sex differences in ibogaine antagonism of morphine-induced locomotor activity and in ibogaine brain levels and metabolism","volume":"57","author":"Pearl","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"5-6","key":"10.1016\/j.ejphar.2022.175454_bib33","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/FBP.0b013e32830cd80f","article-title":"Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions","volume":"19","author":"Perona","year":"2008","journal-title":"Behav. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175454_bib34","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s002130050555","article-title":"Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test","volume":"136","author":"R\u00e9n\u00e9ric","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2022.175454_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108238","article-title":"Sub-chronic vortioxetine (but not escitalopram) normalizes brain rhythm alterations and memory deficits induced by serotonin depletion in rats","volume":"178","author":"Riga","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2022.175454_bib36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neuropharm.2016.04.023","article-title":"Involvement of 5-HT3 receptors in the action of vortioxetine in rat brain: focus on glutamatergic and GABAergic neurotransmission","volume":"108","author":"Riga","year":"2016","journal-title":"Neuropharmacology"},{"issue":"11","key":"10.1016\/j.ejphar.2022.175454_bib37","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1021\/acschemneuro.0c00152","article-title":"A single administration of the atypical psychedelic ibogaine or its metabolite noribogaine induces an antidepressant-like effect in rats","volume":"11","author":"Rodr\u0131guez","year":"2020","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175454_bib38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12640-014-9482-z","article-title":"DSP4, a selective neurotoxin for the locus coeruleus noradrenergic system. A review of its mode of action","volume":"27","author":"Ross","year":"2015","journal-title":"Neurotox. Res."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175454_bib39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bbr.2005.12.001","article-title":"Factor analysis of forced swimming test, sucrose preference test and open field test on enriched, social and isolated reared rats","volume":"169","author":"S\u00e1enz","year":"2006","journal-title":"Behav. Brain Res."},{"issue":"48","key":"10.1016\/j.ejphar.2022.175454_bib40","doi-asserted-by":"crossref","first-page":"13151","DOI":"10.1523\/JNEUROSCI.3772-07.2007","article-title":"Differential effects of serotonin and dopamine on human 5-HT3A receptor kinetics: interpretation within an allosteric kinetic model","volume":"27","author":"Solt","year":"2007","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.ejphar.2022.175454_bib41","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.ejphar.2022.175454_bib42","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.brainres.2004.07.041","article-title":"Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect in the mouse forced swimming test","volume":"1023","author":"Zomkowski","year":"2004","journal-title":"Brain Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922007154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922007154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:51:21Z","timestamp":1778633481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299922007154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":42,"alternative-id":["S0014299922007154"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.175454","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"(+)-Catharanthine and (-)-18-methoxycoronaridine induce antidepressant-like activity in mice by differently recruiting serotonergic and norepinephrinergic neurotransmission","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.175454","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"175454"}}